Mark McDade, CEO at PDL BIOPHARMA, INC. (PDLI), sold 18,698 shares at $20.28 ($380K) on 2007-01-03, disclosed to the SEC on 2007-01-04.
Scheduled sale ($380k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.03 | 2,000 | $40K | 10.6% |
| 2 | $20.23 | 101 | $2K | 0.5% |
| 3 | $20.25 | 900 | $18K | 4.8% |
| 4 | $20.27 | 6,700 | $136K | 35.8% |
| 5 | $20.28 | 200 | $4K | 1.1% |
| 6 | $20.29 | 797 |
| $16K |
| 4.3% |
| 7 | $20.00 | 2,000 | $40K | 10.5% |
| 8 | $20.51 | 2,000 | $41K | 10.8% |
| 9 | $20.53 | 4,000 | $82K | 21.6% |
| Total | $20.30 avg | 18,698 | $380K | 100% |
| Filing → |
| AIMT | BUY | 2015-08-11 | $267K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-07-17 | $9K | — | Filing → |
| PrivatePHILLIPS EDISON GROCERY CENTER REIT II, INC. | BUY | 2015-05-08 | $9K | — | Filing → |